Close
Close

Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital

Access Programs

Disease Information

Descriptive Information
Brief Title † Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
Official Title † Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
Brief Summary Retrospective study of all patients diagnosed with primary biliary cholangitis during January 2001 to July 2016 at West China Hospital by review of medical records. The following variables will be retrospectively studied: age, sex, first symptoms, clinical characteristics, pathology, treatment, stage, complications of cirrhosis, other autoimmune diseases and long-term outcome.
Detailed Description
Study Phase N/A
Study Type † Observational
Study Design †
Primary Outcome Measure † Description of demographics, management patterns (clinical and diagnostic), comorbidities of PBC patients at diagnosis during the past 16 years.
Secondary Outcome Measure † Evaluation of adverse outcome free survival of the PBC cohort during the 16 years.
Condition † Cholangitis Liver Cirrhosis, Biliary Cholestasis Liver Diseases Liver Cirrhosis Bile Duct Diseases
Intervention †
Study Arms / Comparison Groups Primary biliary cholangitis during January 2001 to July 2016
Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information
Recruitment Status †
Estimated Enrollment † 769
Start Date † September 2016
Completion Date January 2017
Primary Completion Date January 2017
Eligibility Criteria † Inclusion Criteria: - Newly diagnosis of PBC at West China Hospital during January 2001 to July 2016. Exclusion Criteria: - Simultaneously diagnosed of autoimmune hepatitis or primary sclerosing cholangitis.
Gender All
Ages 18 Years - N/A
Accepts Healthy Volunteers No
Contacts ††
Location Countries † China
Administrative Information
NCT ID † NCT02917408
Organization ID PBC-1
Secondary IDs ††
Responsible Party Sponsor-Investigator
Study Sponsor † Xiaoli Fan
Collaborators ††
Investigators † Study Chair: Li Yang, MD, West China Hospital,Chengdu, Sichuan, China
Information Provided By
Verification Date June 2017
First Received Date † September 6, 2016
Last Updated Date June 12, 2017
† Required WHO trial registration data element.
†† WHO trial registration data element that is required only if it exists.
Find a Clinical Trial
Trending videos
by Abidemi Uruejoma
29,239 views
by Christine DuBois
23,789 views
by Abidemi Uruejoma
21,619 views
Free Newsletter